RT @DrGustavoDuque: Our #osteosarcopenia & #geroscience research program @AIMSSresearch is working on identifying robust #biomarkers for ag…
Our #osteosarcopenia & #geroscience research program @AIMSSresearch is working on identifying robust #biomarkers for age-related #musculoskeletal diseases and #frailty: https://t.co/BzesiaMNl7 https://t.co/zDve0or2Mj https://t.co/ft12Snz9yz https://t.
RT @DrGustavoDuque: Current and emerging #biomarkers for frailty in the #elderly: https://t.co/wsxIm2VLbY #COPcells #LaminA
RT @DrGustavoDuque: Current and emerging #biomarkers for frailty in the #elderly: https://t.co/wsxIm2VLbY #COPcells #LaminA
RT @DrGustavoDuque: Current and emerging #biomarkers for frailty in the #elderly: https://t.co/wsxIm2VLbY #COPcells #LaminA
RT @DrGustavoDuque: Current and emerging #biomarkers for frailty in the #elderly: https://t.co/wsxIm2VLbY #COPcells #LaminA
RT @DrGustavoDuque: Current and emerging #biomarkers for frailty in the #elderly: https://t.co/wsxIm2VLbY #COPcells #LaminA
Current and emerging #biomarkers for frailty in the #elderly: https://t.co/wsxIm2VLbY #COPcells #LaminA
RT @cardeacl: Resumen sobre la evidencia actual sobre la validez y la practicidad de los biomarcadores más utilizados para la fragilidad. h…
RT @cardeacl: Resumen sobre la evidencia actual sobre la validez y la practicidad de los biomarcadores más utilizados para la fragilidad. h…
Resumen sobre la evidencia actual sobre la validez y la practicidad de los biomarcadores más utilizados para la fragilidad. https://t.co/kIxIaYsF28
RT @DrGustavoDuque: Current and emerging #biomarkers of #frailty in older persons: https://t.co/FaZz4Cd10N #COPcells #laminA #stemcells @AI…
Current and emerging #biomarkers of #frailty in older persons: https://t.co/FaZz4Cd10N #COPcells #laminA #stemcells @AIMSSresearch @UoM_Med_Western @western_health
RT @GRUPOCRONOSSEF1: Current and emerging biomarkers of frailty in the elderly Disponible en: https://t.co/3eq5HQu0sy
Current and emerging biomarkers of frailty in the elderly Disponible en: https://t.co/3eq5HQu0sy
Current and emerging biomarkers of frailty in the elderly. https://t.co/o23Aco3nL9
RT @DrGustavoDuque: Symposium @ #PALTC19 on how to operationalize frailty in #nursing_homes. #biomarkers are needed: https://t.co/FaZz4CuCpn
RT @DrGustavoDuque: Current and emerging #biomarkers of #frailty in the elderly: https://t.co/FaZz4CuCpn
Symposium @ #PALTC19 on how to operationalize frailty in #nursing_homes. #biomarkers are needed: https://t.co/FaZz4CuCpn
Current and emerging #biomarkers of #frailty in the elderly: https://t.co/FaZz4CuCpn
RT @DrAhmedAlSaedi: Check our new review: Current and emerging biomarkers of frailty in the elderly | CIA @DovePress https://t.co/RSXg1a0gF…
RT @DrAhmedAlSaedi: Check our new review: Current and emerging biomarkers of frailty in the elderly | CIA @DovePress https://t.co/RSXg1a0gF…
RT @DrAhmedAlSaedi: Check our new review: Current and emerging biomarkers of frailty in the elderly | CIA @DovePress https://t.co/RSXg1a0gF…
RT @DrAhmedAlSaedi: Check our new review: Current and emerging biomarkers of frailty in the elderly | CIA @DovePress https://t.co/RSXg1a0gF…
Check our new review: Current and emerging biomarkers of frailty in the elderly | CIA @DovePress https://t.co/RSXg1a0gFd @AIMSSresearch @frailty @biomarkers
[Article Metrics] Current and emerging biomarkers of frailty in the elderly | CIA @DovePress https://t.co/j6J5ib2f2d